James C Foster bought $1.0M of Charles River Laboratories Inte (CRL)

Executed Feb 20 2025, disclosed Feb 21 2025, 1 day later.

Value, as filed

$1.0M

6,075 sh × $165.01

Executed

Feb 20 2025

the trade date, as filed

Disclosed

Feb 21 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+3.0%

+0.2% from execution

Over the 21 trading sessions from the disclosed entry session (Feb 21 2025), the stock returned +3.0% (delay-adjusted); from the execution session (Feb 20 2025), +0.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

JF James C Foster Director profile →

James C Foster (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Charles River Laboratories Inte (CRL). The largest single filing was $16.9M of CRL (75,000 sh × $225.00, as filed), executed Jun 29.

The name

CRL Charles River Laboratories Inte CRL · Healthcare · 19 filings in 24 months ticker →

Healthcare · Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by James C Foster in CRL

CRLSALE Charles River Laboratories Inte $10.1M
33,561 sh × $300.00
Exec Aug 25
Filed Aug 27 · 4:21 PM ET CRLSALE Charles River Laboratories Inte $7.9M
28,733 sh × $275.00
Exec Aug 10
Filed Aug 11 · 4:35 PM ET CRLSALE Charles River Laboratories Inte $16.9M
75,000 sh × $225.00
Exec Jun 29
Filed Jul 1 · 4:59 PM ET